Processing Your Payment
Please do not leave this page until complete. This can take a few moments.
- News
-
Editions
View Digital Editions
Biweekly Issues
- October 2, 2023
- Sept. 18, 2023
- Sept. 4, 2023
- August 21, 2023
- August 7, 2023
- July 24, 2023
- July 10, 2023
- June 26, 2023
- June 12, 2023
- + More
Special Editions
- Lists
- Viewpoints
-
HBJ Events
Event Info
- View all Events
- Best Places to Work in Connecticut 2024
- C-Suite and Lifetime Achievement Awards 2023
- The Business of Cannabis: CT Cannabis Conference
- Connecticut's Health Care Heroes Awards 2023
- 40 Under Forty Awards 2023
- 2023 Best Personal Injury Firms
- 2023 Cybersecurity Forum
Award Honorees
- Business Calendar
- Custom Content
Bioscience
Bioscience: Harnessing AI for drug development
Michelle Tuccitto Sullo September 18, 2023Several Connecticut biotech companies are leveraging artificial intelligence to develop new treatments for ailments — from cancer to agitation.
Michelle Tuccitto Sullo September 18, 2023
Capital Crunch: Lack of IPO activity slows growth of CT’s bioscience, tech industries
Harriet Jones, Hartford Business Journal Contributor August 7, 2023A tiny flurry of Connecticut IPO activity in June of this year — as Branford-based biotech Azitra raised $7.5 million, and Westport’s Intensity Therapeutics sold shares worth $16 million — only served to highlight how quiet the markets have been so
Harriet Jones, Hartford Business Journal Contributor August 7, 2023
New Haven digital health startup Wellinks names new CEO
Greg Bordonaro July 14, 2023New Haven-based digital healthcare firm Wellinks, which has developed virtual tools to treat chronic obstructive pulmonary disease (COPD), has named a new CEO.
Greg Bordonaro July 14, 2023
With $150M raised, Enko brings artificial intelligence to pesticide development
Harriet Jones, Hartford Business Journal Contributor June 26, 2023Jacqueline Heard's startup company is at the heart of the data-driven agriculture movement, applying artificial intelligence to developing a new generation of pesticides that she hopes will meet the tough challenges facing farmers who must feed a
Harriet Jones, Hartford Business Journal Contributor June 26, 2023
New Haven-based Bioasis to suspend operations
Michelle Tuccitto Sullo June 21, 2023Bioasis Technologies Inc., a New Haven-based biopharmaceutical company, announced Tuesday it will suspend operations, citing a lack of cash. The announcement comes following a failed merger agreement with U.K.-based Midatech Pharma.
Michelle Tuccitto Sullo June 21, 2023-
New BioCT leader Gillon says boosting venture funding, bioscience talent pipeline key priorities
Michelle Tuccitto Sullo June 12, 2023Jodie Gillon, an advocate in the healthcare field for years, has taken over as president and CEO of BioCT, which serves as the voice for Connecticut’s bioscience industry.
Michelle Tuccitto Sullo June 12, 2023
Quantum-Si unveils new Branford headquarters
Michelle Tuccitto Sullo June 6, 2023Medical technology company Quantum-Si Inc. debuted its new 29,420-square-foot headquarters in Branford Tuesday. The Guilford-born company’s new home is at 29 Business Park Drive, Suite C.
Michelle Tuccitto Sullo June 6, 2023
Biohaven seeks drug approval for rare neurological disorder
Michelle Tuccitto Sullo June 1, 2023New Haven-based biotech company Biohaven Ltd. has submitted a new drug application to the U.S. Food and Drug Administration for troriluzole, its potential treatment for Spinocerebellar Ataxia Type 3.
Michelle Tuccitto Sullo June 1, 2023
Abcam to shutter Branford facility, lay off workers
Michelle Tuccitto Sullo May 26, 2023Life sciences company AxioMx Inc., doing business as Abcam, notified the state this week that it plans to permanently close its Branford operations, resulting in up to 32 layoffs.
Michelle Tuccitto Sullo May 26, 2023
German life sciences company Eppendorf expands Enfield footprint with new distribution center
Hanna Snyder Gambini May 3, 2023Global life sciences company Eppendorf North America Inc. is expanding its Connecticut footprint with the debut of a new Enfield distribution center.
Hanna Snyder Gambini May 3, 2023
BioCT names Jodie Gillon as president and CEO
Andrew Larson May 1, 2023BioCT, a statewide bioscience industry group, has named Jodie Gillon as its new president and CEO. Gillon will replace Dawn Hocevar, who retired last week after more than five years in the position, starting May 8.
Andrew Larson May 1, 2023
Biotech company announces new CT location
Andrew Larson January 31, 2023A biotechnology company has announced that it will open a manufacturing and distribution operation in Stamford, according to AdvanceCT, a nonprofit that promotes business in Connecticut.
Andrew Larson January 31, 2023
Sema4 settles up with CT after relocating labs out of the state
Erica E. Phillips, CT Mirror January 13, 2023The Connecticut Department of Economic and Community Development has renegotiated the terms of a $15.5 million incentive deal with biotechnology startup Sema4 after the company shuttered its laboratory operations in the state.
Erica E. Phillips, CT Mirror January 13, 2023
Farmington biotech developing cancer vaccine for pets raises $13M
Andrew Larson November 17, 2022Torigen Pharmaceuticals, which is developing a cancer vaccine for pets, announced Wednesday it had closed on a $13 million round of venture capital financing.
Andrew Larson November 17, 2022-
Sema4 closes CT labs, cuts hundreds of jobs
Erica E. Phillips and Dave Altimari, CT Mirror November 14, 2022In a conference call with analysts Monday announcing Sema4’s third quarter earnings, Chief Executive Katherine Stueland said the company was eliminating its reproductive health business, cutting 500 jobs and closing its 70,000-square-foot laboratory
Erica E. Phillips and Dave Altimari, CT Mirror November 14, 2022 
CT biotech firm announces $50M public offering for development programs
Andrew Larson November 14, 2022After going public in July 2021, biotech startup Rallybio Corp. is seeking to raise an additional $50 million through an offering of 5 million shares at $6 per share.
Andrew Larson November 14, 2022
Today's Poll
The federal government is heading toward a shutdown unless Congress passes funding legislation that is signed into law before Oct. 1.
Hundreds of thousands of government workers won't get paid until the shutdown is over, and many federal government services will be suspended.
Economists say the longer the shutdown lasts, the more severe the effects will be.
According to accounting firm EY, a shutdown would take 0.1 of a percentage point off of GDP every week.
2022 Giving Guide
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn more
Subscribe
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Subscribe
2023 Book of Lists
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read Here-
2022 Giving Guide
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
-
Subscribe
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
-
2023 Book of Lists
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
ABOUT
ADVERTISE
NEW ENGLAND BUSINESS MEDIA SITES
No articles left
Get access now
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy